Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cour Pharmaceuticals Development
AddedFeb 15, 2024
UpdatedJun 18, 2026
Cour Pharmaceuticals Development

Cour Pharmaceuticals Development

Series A

Cour Pharmaceuticals: Advancing nanoparticle tech to reset MS patients' immune systems.

HQ
Skokie, IL, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Cour Pharmaceuticals is focused on developing first-in-class therapies designed to reprogram the immune system to achieve antigen-specific tolerance for immune-mediated diseases. Their core technology involves immune-modifying nanoparticles that aim to treat the root cause of these diseases rather than merely minimizing symptoms. The company's lead product targets celiac disease, and they are also working on treatments for multiple sclerosis (MS) patients.

Cour Pharmaceuticals has made significant strides in the biotechnology sector by advancing nanoparticle technology to reset immune systems. Their innovative approach has the potential to transform treatment paradigms for various immune-mediated conditions. The company has garnered attention for its pioneering work and has established partnerships to further its research and development efforts.

Cour Pharmaceuticals Development - Similar Companies

AnTolRx logo

AnTolRx

antolrx.com

Cello Therapeutics logo

Cello Therapeutics

cellothera.com

Nano Cures logo

Nano Cures

nanocures.com

NanoPharmaceuticals logo

NanoPharmaceuticals

Emerald Health Pharmaceuticals logo

Emerald Health Pharmaceuticals

Advanced NanoTherapies logo

Advanced NanoTherapies

Exicure logo

Exicure

2C Tech logo

2C Tech

Selecta Biosciences logo

Selecta Biosciences

selectabio.com

CuraSen Therapeutics logo

CuraSen Therapeutics

curasen.com

Cellics Therapeutics logo

Cellics Therapeutics

cellics.com

Kurve Therapeutics logo

Kurve Therapeutics

kurvetx.com

Camino Pharma logo

Camino Pharma

caminopharma.com

Curtana Pharmaceuticals logo

Curtana Pharmaceuticals

curtanapharma.com

Courage Therapeutics logo

Courage Therapeutics

Cour Pharmaceuticals Development - Quick Facts

Who are Cour Pharmaceuticals Development's competitors?

Companies similar to Cour Pharmaceuticals Development include AnTolRx, Cello Therapeutics, Nano Cures and NanoPharmaceuticals.

When was Cour Pharmaceuticals Development founded?

Cour Pharmaceuticals Development was founded in 2015.

Where is Cour Pharmaceuticals Development's headquarters located?

Cour Pharmaceuticals Development's headquarters is located in Skokie, IL, US.

When was Cour Pharmaceuticals Development's last funding round?

Cour Pharmaceuticals Development's most recent funding round was for $105M (USD) in January 2024.

How much has Cour Pharmaceuticals Development raised to-date?

As of Jan 30, 2024, Cour Pharmaceuticals Development has raised a total of $135.5M (USD).

How many employees does Cour Pharmaceuticals Development have?

Cour Pharmaceuticals Development has 49 employees as of Feb 5, 2024.

Cour Pharmaceuticals Development - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Nanotechnology
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Nanoparticles
  • Therapies
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified